CAN EVRA PATCH SOLVE TEEN PREGNANCY

 Madam,

 Eswatini continues to face the significant challenge of high adolescent pregnancy rates, which strain the healthcare system and jeopardise the future of our youth. As a nurse midwife and maternal, child, and adolescent health researcher, I have observed the dedication of Sexual and Reproductive Health (SRH) programmes in educating and supporting adolescents to improve their well-being. Despite these commendable efforts, persistent shortages of essential medications, limited resources, and varying levels of maternal health literacy continue to hinder the effectiveness of SRH interventions.

 To strengthen existing SRH programmes, I propose incorporating the Evra Patch as an additional contraceptive option for adolescents. The Evra Patch is a transdermal contraceptive that delivers two hormones, ethinyl estradiol and norelgestromin, through the skin to prevent pregnancy. These hormones work together to stop ovulation (the release of an egg), thicken cervical mucus to make it difficult for sperm to reach an egg, and alter the lining of the uterus to reduce the chances of a fertilised egg attaching.

 The patch is applied to areas such as the upper arm, back, stomach, or buttocks and is changed once a week for three consecutive weeks, followed by a patch-free week to allow for a menstrual period. This simple, weekly application schedule provides a non-invasive, easy-to-use alternative to daily birth control pills, which can be difficult for some adolescents to remember consistently.By offering a reliable method that fits into their lifestyle, the Evra Patch can improve adherence and reduce the risk of unintended pregnancies. Integrating the Evra Patch can empower adolescents with greater control over their reproductive health, leading to better educational outcomes and long-term economic prospects.

 This approach can also ease pressure on healthcare systems by reducing the incidence of adolescent pregnancies. Additionally, the introduction of new contraceptive options should align with existing HIV prevention and education efforts, recognising the interconnected nature of reproductive health and HIV prevention. Eswatini’s commitment to the well-being of its youth is evident. By adopting innovative, evidence-based solutions that reflect this generation’s needs and realities, we can make meaningful strides towards securing a healthier, brighter future for our adolescents. Thank you for considering this important perspective.I am confident that, together, we can drive significant and positive change for the youth of Eswatini.

Zama Mkhonta
Nurse Midwife, RFM Hospital

RIGHT TO REPLY

 Before using any health products such as a contraceptives is essential to consult your doctor or health care specialist. When it comes to contraceptives, the Ministry of Health in Eswatini is guided by the World Health Organization (WHO) and the United Nations Children's Fund (UNICEF).  

  There isn't much information about whether the World Health Organization (WHO) has approved the Evra patch as a safe contraceptive method, but here's some information about the Evra patch and its approval by the European Medicines Agency (EMA) and the US Food and Drug Administration (FDA).

 The EMA decided that the benefits of Evra outweigh its risks for female contraception and recommended that it be given marketing authorisation. However, the patch is not considered safer than oral birth control pills. Though it is more than 99 per cent effective when used correctly, in real-world use, about 8 in 100 people become pregnant each year because they forget to change the patch. 

 The FDA has updated the labeling of the Evra patch to warn patients and providers that it exposes women to higher levels of estrogen than most birth control pills. The FDA has also issued a black box warning for Ortho Evra, which was updated in 2011. The FDA's Joint Advisory Committee recommended that Ortho Evra remain on the market, but that the label be revised to more clearly describe the risks and benefits. According to FDA, Common side effects include headaches, skin irritation, nausea, and breast tenderness. Rare side effects include developing blood clots. 

 Ed

Post your comment

Your name:

Your e-mail address:

Add your comments:

Please enter the code you see in the image:

Image:

Code: